Up-regulation of the estrogen receptor by triiodothyronine in rat pituitary cell lines

Journal of Steroid Biochemistry and Molecular Biology

Volumn 61, Issue 1-2, 1997, Pages 79-85

  Fujimoto, Nariaki ^a   Watanabe, Hiromitsu ^a   Akihiro, Ito ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; GROWTH HORMONE; LIOTHYRONINE; LIOTHYRONINE RECEPTOR; MESSENGER RNA; RETINOIC ACID RECEPTOR; THYROID HORMONE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; HYPOPHYSIS CELL; IN VITRO STUDY; NONHUMAN; RAT; RECEPTOR UPREGULATION; RNA ANALYSIS;

ANIMALS; CELL DIVISION; CYCLOHEXIMIDE; ESTRADIOL; FEMALE; GROWTH HORMONE; PITUITARY GLAND; PITUITARY NEOPLASMS; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, INBRED F344; RECEPTORS, ESTROGEN; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; RNA, MESSENGER; TRETINOIN; TRIIODOTHYRONINE; TUMOR CELLS, CULTURED; UP-REGULATION;

ANIMALIA;

EID: 0030767111     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00009-5     Document Type: Article

References (30)

1. Furth J., Clifton K. N., Gadsen E. L. and Buffet R. F.: Dependent and autonomous mammotropic pituitary tumors in rats: their somatotropic features. Cancer Res. 16 (1956) 608-616.
2. Ueda G., Takizawa S., Moy P., Marolla F. and Furth J.: Characterization of four transplantable mammotropic pituitary tumor variants in the rat. Cancer Res. 28 (1968) 1963-1975.
3. Morel Y., Alvaladejo V., Bouvier J. and Andre J.: Inhibition by 17β-estradiol of the growth of the rat pituitary transplantable tumor MtF4. Cancer Res. 42 (1982) 1492-1497.
4. Lloyd R. V., Landefled T. D., Maslar I. and Frohman L. A.: Diethylstilbestrol inhibits tumor growth and prolactin production in rat pituitary tumors. Am. J. Pathol. 118 (1985) 608-616.
5. Tashjian A. H., Yasumura Y., Levine L., Sato G. H. and Parker M. L.: Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 82 (1968) 342-352.
6. Ito A., Kawashima K., Fujimoto N., Watanabe H. and Naito M.: Inhibition by 2-bromo-α-ergocriptine and tamoxifen of the growth of an estrogen-dependent transplantable pituitary tumor (MtTF84) in F344 rats. Cancer Res. 45 (1985) 6436-6441.
7. Fujimoto F., Watanabe H. and Ito A.: Direct up-regulation of estrogen receptor by triiodothyronine in rat pituitary tumor MtT/F84. Endocr. Jpn. 38 (1991) 405-412.
8. Fujimoto N. and Katzenellenbogen B. S.: Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence. Molec. Endocr. 8 (1994) 296-304.
9. Jacq X., Brou C., Lutz Y., Davidson I., Chambon P. and Tora L.: Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79 (1994) 107-117.
10. Burris T. P., Nawaz Z., Tsai M. J. and O'Malley B. W.: A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and RA receptors. Proc. NatL Acad. Sci. U.S.A. 92 (1995) 9525-9529.
11. Lippman M., Bolan G. and Huff K.: The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 36 (1976) 4595-4601.
12. Neifeld J. P., Lawrence W., Brown P. W., Banks W. L. and Terz J. J.: Estrogen receptors in primary breast cancer. Arch. Surg. 117 (1982) 753-757.
13. Bergman M. D., Schachter B. S., Karelus K., Combatsiaris E. P., Garcia T. and Nelson J. F.: Up-regulation of the uterine estrogen receptor and its messenger ribonucleic acid during the mouse estrous cycle: the role of estradiol. Endocrinology 130 (1992) 1923-1930.
14. Freyschuss B., Stavreus-Evers A., Sahlin L. and Eriksson H.: Induction of the estrogen receptor by growth hormone and glucocorticoid substitution in primary cultures of rat hepatocytes. Endocrinology 133 (1993) 1548-1554.
15. Vollmer G., Gerdes J. and Knuppen R.: Relationship of cytosolic estrogen and progesterone receptor content and the growth fraction in human mammary carcinomas. Cancer Res. 49 (1989) 4011-4014.
16. Ulisse S. and Tata J. R.: Thyroid hormone and glucocorticoid independently regulate the expression of estrogen receptor in male Xenopus liver cells. Molec. Cell. Endocr. 105 (1994) 45-53.
17. Inoue K., Hattori M., Sakai T., Inukai S., Fujimoto N. and Ito A.: Establishment of a series of pituitary clonal cell lines differing in morphology, hormone secretion, and response to estrogen. Endocrinology 126 (1990) 2313-2320.
18. Scudiero D. A., Shoemaker R. H., Paull K. D., Monks A., Tierney S., Nofziger T. H., Currens M. J., Seniff D. and Boyd M. R.: Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48 (1988) 4827-4833.
19. Grippo J. F. and Gudas L. J.: The effect of dibutyryl cyclic AMP and butyrate on F9 teratocarcinoma cellular retinoic acid-binding protein activity. J. Biol. Chem. 262 (1987) 4492-4500.
20. Koike S., Sakai M. and Muramatsu M.: Molecular cloning and characterization of rat estrogen receptor cDNA. Nucl. Acids Res. 15 (1987) 2499-2513.
21. Wangh L. J. and Schneider W.: Thyroid hormones are corequisites for estradiol-17β in vitro induction of Xenopus vitellogenin synthesis and secretion. Dev. Biol. 89 (1982) 287-293.
22. Fujimoto N., Watanabe H. and Ito A.: Blockade of the estrogen-induced increase in progesterone receptor caused by propylthiouracil, an anti-thyroid drug, in a transplantable pituitary tumor in rats. Endocr. J. 43 (1996) 329-334.
23. Cidlowski J. A. and Muldoon T. G.: Modulation by thyroid hormones of cytoplasmic estrogen receptor concentrations in reproductive tissues of the rat. Endocrinology 97 (1975) 59-67.
24. Altschuler L. R., Ceppi J. A., Ritt M. N., Calandra R. S. and Zaninovich A. A.: Effects of thyroxine on oestrogen receptor concentrations in anterior pituitary and hypothalamus of hypothyroid rats. J. Endocr. 199 (1988) 383-387.
25. Ree A. H., Landmark B. F., Eskild W., Levy F. O., Lahooti H., Jahnsen T., Aakvaag A. and Hansson V.: Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels. Endocrinology 124 (1989) 2577-2583.
26. Read L. D., Greene G. L. and Katzenellenbogen B. S.: Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Molec. Endocr. 3 (1989) 295-304.
27. Borras M., Hardy L., Lempereur F., el-Khissiin A. H., Legros N., Gol-Winkler R. and Leclercq G.: Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J. Steroid Biochem. Molec. Biol. 48 (1994) 325-336.
28. Meredith J. M., Auger C. J. and Blaustein J. D.: Down-regulation of estrogen receptor immunoreactivity by 17β-estradiol in the guinea pig forebrain. J. Neuroendocr. 6 (1994) 639-648.
29. Bedo G., Santisteban P. and Aranda A.: Retinoic acid regulates growth hormone gene expression. Nature 339 (1989) 231-234.
30. Morita S., Fernandez-Mejia C. and Melmed S.: Retinoic acid selectively stimulates growth hormone secretion and messenger ribonucleic acid levels in rat pituitary cells. Endocrinology 124 (1989) 2052-2056.